Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Transplantation
Volume 2014 (2014), Article ID 934385, 3 pages
http://dx.doi.org/10.1155/2014/934385
Case Report

A Symptomatic De Novo Pheochromocytoma 23 Years after Liver Transplantation: A Case Report and Review of the Literature

1Division of Transplantation, Department of Surgery, University of Washington, Seattle, WA, USA
2Department of Anatomic Pathology, University of Washington, Seattle, WA, USA

Received 11 June 2014; Accepted 14 November 2014; Published 14 December 2014

Academic Editor: Marian Klinger

Copyright © 2014 M. I. Montenovo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. Backman, M. Nicar, M. Levy et al., “FK506 trough levels in whole blood and plasma in liver transplant recipients. Correlation with clinical events and side effects,” Transplantation, vol. 57, no. 4, pp. 519–525, 1994. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Saigal, S. Norris, P. Muiesan, M. Rela, N. Heaton, and J. O'Grady, “Evidence of differential risk for posttransplantation malignancy based on pretransplantation caused in patients undergoing liver transplantation,” Liver Transplantation, vol. 8, no. 5, pp. 482–487, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. E. J. Gallagher, R. Courgi, S. Heiba, and R. Tamler, “Resolution of insulin-requiring diabetes in a liver transplant recipient after treatment of a pheochromocytoma: case report and review of literature,” Minerva Endocrinologica, vol. 36, no. 4, pp. 341–345, 2011. View at Google Scholar · View at Scopus
  4. I. Penn, “Occurrence of cancers in immunosuppressed organ transplant recipients,” Clinical Transplants, pp. 147–158, 1998. View at Google Scholar · View at Scopus
  5. I. Penn, C. G. Halgrimson, and T. E. Starzl, “De novo malignant tumors in organ transplant recipients,” Transplantation Proceedings, vol. 3, no. 1, pp. 773–778, 1971. View at Google Scholar · View at Scopus
  6. F. Y. Yao, M. Gautam, C. Palese et al., “De novo malignancies following liver transplantation: a case-control study with long-term follow-up,” Clinical Transplantation, vol. 20, no. 5, pp. 617–623, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. R. Baehner, G. Magrane, R. Balassanian et al., “Donor origin of neuroendocrine carcinoma in 2 transplant patients determined by molecular cytogenetics,” Human Pathology, vol. 31, no. 11, pp. 1425–1429, 2000. View at Publisher · View at Google Scholar · View at Scopus
  8. S. S. Desai, E. Loh, M. L. Kochman, D. Fraker, and D. DeNofrio, “De novo ampullary neuroendocrine tumor in an orthotopic heart transplant recipient,” The American Journal of Gastroenterology, vol. 94, no. 11, pp. 3382–3383, 1999. View at Publisher · View at Google Scholar · View at Scopus
  9. P. Neuhaus, P. McMaster, R. Calne et al., “Neurological complications in the European multicentre study of FK 506 and cyclosporin in primary liver transplantation,” Transplant International, vol. 7, pp. S27–S31, 1994. View at Google Scholar · View at Scopus
  10. C. M. Beard, S. G. Sheps, L. T. Kurland, J. A. Carney, and J. T. Lie, “Occurrence of pheochromocytoma in Rochester, Minnesota, 1950 through 1979,” Mayo Clinic Proceedings, vol. 58, no. 12, pp. 802–804, 1983. View at Google Scholar · View at Scopus
  11. R. E. Goldstein, J. A. O'Neill Jr., G. W. Holcomb III et al., “Clinical experience over 48 years with pheochromocytoma,” Annals of Surgery, vol. 229, no. 6, pp. 755–766, 1999. View at Publisher · View at Google Scholar · View at Scopus